Remdesivir
COVID-19 treatment: SOLIDARITY trial is restarting with 3 drugs this time

The drug candidates for repurposing are imatinib, a cancer drug; infliximab, an antibody; and artesunate, an anti-malarial drug. The tests seek to explore possible drugs that can be repurposed to treat severely affected COVID-19 patients

COVID-19 in India: ‘Need to strengthen public health system’

Immunologist Dr. Satyajit Rath analyses the current COVID-19 crisis in India with Newsclick editor-in-chief Prabir Purkayastha.

Modi government vs COVID-19: A shambolic fight

In tackling the second wave, India’s Central government led by Narendra Modi has been bumbling and groping for solutions, mostly much delayed and inadequate

WHO mega trial results out: Remdesivir, Interferon fail to prove effective

None of the four drug/drug combinations that were deployed in the WHO’s SOLIDARITY trial were found to be effective in reducing mortality, not even the much-hyped anti-viral drug Remdesivir

How can countries overcome US monopoly over Remdesivir?

After making America sick again, president Donald Trump is trying to compensate for his administration’s failure by buying up the entire stock of Remdesivir from Gilead for the next three months for the US, and leaving nothing for the rest of the world.

Break Gilead’s patent since US has bought all stock of Remdesivir

Trump is trying to improve his waning electoral chances by reserving all of Gilead’s stock of Remdesivir to cover up his disastrous handling of the Covid-19 epidemic so far

US Buys Up Remdesivir: We Must Break Patents for Access to COVID-19 Drug

Newsclick’s Prabir Purkayastha discusses the US buying out supplies of the COVID-19 drug, Remdesivir.

COVID-19: Dexamethasone provides some hope for severely ill

In a trial, Dexamethasone, an inexpensive and widely used corticosteroid, reduced deaths by one-third in ventilated patients and by one-fifth in patients receiving oxygen support

World Health Assembly 2020: Is our response to COVID-19 adequate?

Activists of the People’s Health Movement talk about the World Health Assembly that begins today, the key issues that will come up for discussion, and the collapse of the global governance system in the realm of public health

How discovering the structure of SARS-CoV-2 makes antiviral drug design possible

A group of Chinese researchers have successfully decoded the structure of the viral enzyme key to the novel coronavirus’ survival

    × To Subscribe